Literature DB >> 9218510

Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.

P A Muraro1, M Vergelli, M Kalbus, D E Banks, J W Nagle, L R Tranquill, G T Nepom, W E Biddison, H F McFarland, R Martin.   

Abstract

The pathogenesis of multiple sclerosis (MS) is currently ascribed in part to a T cell-mediated process targeting myelin components. The T cell response to one candidate autoantigen, myelin basic protein (MBP), in the context of HLA-DR15Dw2, has been previously studied in detail. However, the characteristics of cellular immunity in the context of other MS-associated HLA-DR haplotypes are scarcely known. MBP-specific T cell lines (TCL) were generated from HLA-DR4 (B1*0401)-positive MS subjects. Out of 275 MBP-specific TCL, 178 (64. 7%) specifically recognized region MBP(111-129), predominantly in the context of DRB1*0401. The major T cell epitope for MBP recognition corresponded to residues MBP(116-123). These TCL expressed disparate profiles of cytokine secretion and cytotoxicity. T cell receptor analysis, on the other hand, revealed a strikingly limited heterogeneity of rearrangements. In contrast to MBP(81-99), which binds with high affinity to HLA-DR15 and is recognized by a diverse T cell repertoire, MBP(111-129) binds weakly to DRB1*0401, suggesting that only high affinity T cell receptors might be able to efficiently engage such unstable MHC/peptide complexes, thus accounting for the T cell receptor restriction we observed. This study provides new insight about MBP recognition and proposes an alternative mechanism for immunodominance of self-antigen T cell epitopes in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218510      PMCID: PMC508196          DOI: 10.1172/JCI119539

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

1.  HLA determinants in familial multiple sclerosis.

Authors:  M G Grasso; F Cutrupi; S Bernardi; S Trabace; C Pozzilli; S Cappellacci; C Fieschi
Journal:  Neuroepidemiology       Date:  1992       Impact factor: 3.282

Review 2.  TCR usage in human and experimental demyelinating disease.

Authors:  D A Hafler; M G Saadeh; V K Kuchroo; E Milford; L Steinman
Journal:  Immunol Today       Date:  1996-04

3.  DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes.

Authors:  C B Sanjeevi; P Höök; M Landin-Olsson; I Kockum; G Dahlquist; T P Lybrand; A Lernmark
Journal:  Tissue Antigens       Date:  1996-04

4.  Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein.

Authors:  S Brocke; K Gijbels; M Allegretta; I Ferber; C Piercy; T Blankenstein; R Martin; U Utz; N Karin; D Mitchell; T Veromaa; A Waisman; A Gaur; P Conlon; N Ling; P J Fairchild; D C Wraith; A O'Garra; C G Fathman; L Steinman
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

5.  Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity.

Authors:  Z Jingwu; R Medaer; G A Hashim; Y Chin; E van den Berg-Loonen; J C Raus
Journal:  Ann Neurol       Date:  1992-09       Impact factor: 10.422

Review 6.  Immunological aspects of demyelinating diseases.

Authors:  R Martin; H F McFarland; D E McFarlin
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

7.  Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes.

Authors:  G Giegerich; M Pette; E Meinl; J T Epplen; H Wekerle; A Hinkkanen
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

8.  Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis.

Authors:  T Olsson; J Sun; J Hillert; B Höjeberg; H P Ekre; G Andersson; O Olerup; H Link
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

9.  Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.

Authors:  R Martin; U Utz; J E Coligan; J R Richert; M Flerlage; E Robinson; R Stone; W E Biddison; D E McFarlin; H F McFarland
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

10.  Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.

Authors:  U Utz; D Banks; S Jacobson; W E Biddison
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more
  25 in total

1.  Lack of restriction of T cell receptor beta variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis.

Authors:  R N Heard; S M Teutsch; B H Bennetts; S D Lee; E M Deane; G J Stewart
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

Review 2.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

3.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

4.  Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Authors:  Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans Georg Rammensee; Robert Weissert
Journal:  Mol Cell Proteomics       Date:  2009-06-16       Impact factor: 5.911

5.  Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.

Authors:  Hiroko Miyadera; Jun Ohashi; Åke Lernmark; Toshio Kitamura; Katsushi Tokunaga
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

Review 6.  Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.

Authors:  Hiroko Miyadera; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

7.  Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Authors:  Paolo A Muraro; Klaus-Peter Wandinger; Bibiana Bielekova; Bruno Gran; Adriana Marques; Ursula Utz; Henry F McFarland; Steve Jacobson; Roland Martin
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

8.  A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?

Authors:  Kerrie Vaughan; Bjoern Peters; Kevin C O'Connor; Roland Martin; Alessandro Sette
Journal:  J Neuroimmunol       Date:  2013-12-12       Impact factor: 3.478

9.  Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Authors:  Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth M Cameron; Andrea Jowdry; E Sally Ward; Elliot Frohman; Michael K Racke; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2007-04-23       Impact factor: 3.478

10.  HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; Omar Dominguez-Amorocho; Lawrence J Stern
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.